Irene Rosenberg, MD
Dermatology · Woodmere, NYNPI 1932187648
Payments from drug & device makers
What this record shows
This record is dominated by education: $402 of the $496 with a category attached, or 81.1%. Sanofi-aventis U.S. LLC accounts for 65.0% of it on its own, with 4 other manufacturers making up the rest. 2025 is the largest year on record at $169, 2.1 times the $80 reported in 2021. That places this record below the midpoint for dermatology clinicians in NY, where the typical reported total is $2,360.
Across 10 payments — averaging $49.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sanofi-aventis U.S. LLC$322
- Regeneron Healthcare Solutions, Inc.$80
- GSK$53
- Novartis$26
- AbbVie$15
What the payments were for
- Food & beverage$9419%
- Education$40281%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sanofi-aventis U.S. LLC | 4 | $322 |
| Regeneron Healthcare Solutions, Inc. | 1 | $80 |
| GSK | 3 | $53 |
| Novartis | 1 | $26 |
| AbbVie | 1 | $15 |
How this compares
$496 in reported general payments places this provider in the 25th percentile of 1,151 dermatology providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Fluorouracil | 23 | $1,525 |
| Halobetasol Propionate | 26 | $1,515 |
| Ketoconazole | 61 | $1,413 |
| Clobetasol Propionate | 30 | $1,285 |
| Imiquimod | 34 | $1,241 |
| Levocetirizine Dihydrochloride | 23 | $874 |
| Mometasone Furoate | 46 | $750 |
| CiclopiroxCiclopirox Olamine | 38 | $712 |
| Betamethasone Diprop AugmentedBetamethasone/Propylene Glyc | 52 | $696 |
| Triamcinolone Acetonide | 60 | $516 |
| Doxycycline Hyclate | 22 | $508 |
| Metronidazole | 13 | $441 |
| Alclometasone Dipropionate | 15 | $437 |
| ValacyclovirValacyclovir Hcl | 23 | $436 |
| Minocycline Hcl | 13 | $362 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Woodmere
- Alexandra GolantNew York$3.6M
- David CohenNew York$3M
- Michael CameronNew York$2.6M
- Saakshi KhattriNew York$2.4M
- Amy WechslerNew York$2.4M
- Jeffrey WeinbergKew Gardens$2.3M
- Joshua ZeichnerNew York$2.1M
- Russell CohenOceanside$2.1M
- Jeffrey LaducaAuburn$1.9M
- Emma GuttmanNew York$1.7M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.